Specialty Pharmacy

Top news of the day from across the health care landscape.

Patients who achieved hepatitis C virus eradication experienced a reduction in hepatic steatosis and fibrosis.

Combining oncolytic viruses and immunotherapies may fight cancer more effectively.

Treatment with durvalumab (Imfinzi) reduces the risk of disease progression among patients with non-small cell lung cancer.

Enzalutamide (Xtandi) demonstrates a significant reduction in metastasis or death from castration-resistant prostate cancer

Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, speaks to the difficulties that face manufacturers who are launching a novel specialty product.

PRDM14 is involved with embryonic development and may lead to germ cell tumors.

Top news of the day from across the health care landscape.

Many key specialty pharmacy issues discussed at the Payer/Managed Care Strategies for Specialty Medications Annual Symposium.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Crystalized dolutegravir may be able to reach viral reservoirs and cure HIV.

Lorlatinib was designed to bypass non-small cell lung cancer mutations that promote drug resistance

A gene that plays a crucial role in blood cell maturation can mutate and cause cancer to develop.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Rituximab (Rituxan) sparked remission among patients with pemphigus vulgaris.

A popular multiple sclerosis drug may increase the risk of a potentially-fatal brain infection.

A recent report highlights how Americans pay more for prescription drugs compared with other countries.

Less serious adverse events remain a concern for patients treated for chronic diseases.

Top news of the day from across the health care landscape.

Many pharmacists are turning to credentialing as a way to distinguish themselves professionally.

Surgeons may play an integral role in preventing opioid dependency in surgery patients.

Apalutamide (Erleada) was approved based on metastasis-free survival, which is a new clinical endpoint.

Tisagenlecleucel (Kymriah) induced remission in a patient with acute lymphoblastic leukemia who was seemingly out of options.

Current production methods make it difficult to mass produce an effective HIV vaccine.

An existing drug can prevent cancerous stem cells from reproducing, without the toxic adverse effects of chemotherapy.

An executive order allows New York pharmacists to administer the influenza vaccine to children.

Top news of the day from across the health care landscape.